[
    {
        "text": "This episode was filmed on April 2nd 2021.",
        "start": 0.149,
        "duration": 3.021
    },
    {
        "text": "For our most up to date coverage of the COVID-19\npandemic,",
        "start": 3.17,
        "duration": 3.15
    },
    {
        "text": "be sure to check out the playlist linked in\nthe description.",
        "start": 6.32,
        "duration": 6.899
    },
    {
        "text": "[♪ INTRO]",
        "start": 13.219,
        "duration": 5.161
    },
    {
        "text": "Even though scientists have learned a whole\nlot about COVID-19,",
        "start": 18.38,
        "duration": 2.879
    },
    {
        "text": "this pandemic has also highlighted the fact\nthat there’s",
        "start": 21.259,
        "duration": 2.131
    },
    {
        "text": "a lot we don’t know about our immune systems.",
        "start": 23.39,
        "duration": 2.389
    },
    {
        "text": "Like, one thing that’s really throwing researchers\nfor a loop is that",
        "start": 25.779,
        "duration": 2.81
    },
    {
        "text": "a fair number of people who catch the SARS-CoV-2\nvirus just…",
        "start": 28.589,
        "duration": 4.231
    },
    {
        "text": "don’t show any signs of being infected.",
        "start": 32.82,
        "duration": 1.91
    },
    {
        "text": "No one’s quite sure how prevalent these\nsymptomless, or asymptomatic cases are.",
        "start": 34.73,
        "duration": 4.49
    },
    {
        "text": "And that’s especially concerning for a disease\nthat lands between",
        "start": 39.22,
        "duration": 2.61
    },
    {
        "text": "five and thirty percent of people in the hospital!",
        "start": 41.83,
        "duration": 2.5
    },
    {
        "text": "What researchers are fairly sure of, though,\nis that there isn’t one answer to",
        "start": 44.33,
        "duration": 3.29
    },
    {
        "text": "why people don’t feel the effects of SARS-CoV-2.",
        "start": 47.62,
        "duration": 2.99
    },
    {
        "text": "And looking deeper into the many potential\nexplanations will",
        "start": 50.61,
        "duration": 2.51
    },
    {
        "text": "teach us a lot about how our bodies fight\npathogens.",
        "start": 53.12,
        "duration": 2.57
    },
    {
        "text": "Now, technically, everyone with COVID-19 starts\nout symptom-free,",
        "start": 55.69,
        "duration": 3.96
    },
    {
        "text": "or presymptomatic.",
        "start": 59.65,
        "duration": 1.49
    },
    {
        "text": "No one is coughing the instant the first virus\ngets into one of their cells",
        "start": 61.14,
        "duration": 3.71
    },
    {
        "text": "and convinces it to start churning out more\nviruses.",
        "start": 64.85,
        "duration": 2.35
    },
    {
        "text": "There is an incubation period, and it can\ntake anywhere from a few days",
        "start": 67.2,
        "duration": 3.22
    },
    {
        "text": "to two weeks for people to start to feel an\ninfection.",
        "start": 70.42,
        "duration": 3.16
    },
    {
        "text": "Also, what ”feeling it” looks like varies.",
        "start": 73.58,
        "duration": 2.39
    },
    {
        "text": "It could be milder signs like a duller sense\nof taste or smell,",
        "start": 75.97,
        "duration": 3.78
    },
    {
        "text": "all the way to life-threatening breathing\ndifficulties or heart problems.",
        "start": 79.75,
        "duration": 3.24
    },
    {
        "text": "Doesn’t matter where a person falls on that\nspectrum;",
        "start": 82.99,
        "duration": 2.45
    },
    {
        "text": "even mild symptoms make a case count as a\nsymptomatic infection.",
        "start": 85.44,
        "duration": 3.13
    },
    {
        "text": "It’s also important to note that having\nan asymptomatic case of COVID-19",
        "start": 88.57,
        "duration": 3.37
    },
    {
        "text": "doesn’t mean there aren’t any effects\non the body long-term.",
        "start": 91.94,
        "duration": 3.75
    },
    {
        "text": "Scientists are still keeping an eye on whether\nasymptomatic infections",
        "start": 95.69,
        "duration": 2.45
    },
    {
        "text": "can trigger symptoms down the line.",
        "start": 98.14,
        "duration": 1.45
    },
    {
        "text": "But being asymptomatic clearly lessens the\nodds of",
        "start": 99.59,
        "duration": 2.6
    },
    {
        "text": "requiring emergency medical care off the bat.",
        "start": 102.19,
        "duration": 2.54
    },
    {
        "text": "And one thing that stands out right away is\nthat some groups of people tend to",
        "start": 104.73,
        "duration": 3.16
    },
    {
        "text": "be less prone to severe cases, like kids.",
        "start": 107.89,
        "duration": 3.05
    },
    {
        "text": "As a group, people under the age of 18, and\nbetween the ages of 2 and 13 in particular,",
        "start": 110.94,
        "duration": 5.62
    },
    {
        "text": "seem to be less likely to contract COVID-19\nand less likely to experience symptoms if",
        "start": 116.56,
        "duration": 4.64
    },
    {
        "text": "they do.",
        "start": 121.2,
        "duration": 1.0
    },
    {
        "text": "And this might be because once a child's immune\nsystem is established, novelty is it's forte.",
        "start": 122.2,
        "duration": 4.419
    },
    {
        "text": "Kids are newcomers to the world, so they haven’t\nencountered the myriad",
        "start": 126.619,
        "duration": 2.98
    },
    {
        "text": "of disease-causing agents that grown-ups have.",
        "start": 129.599,
        "duration": 2.331
    },
    {
        "text": "And since SARS-CoV-2 is novel to everyone,",
        "start": 131.93,
        "duration": 4.08
    },
    {
        "text": "kids seem to have some advantages that help\nthem clear it more quickly and efficiently,",
        "start": 136.01,
        "duration": 3.97
    },
    {
        "text": "often before they feel symptoms.",
        "start": 139.98,
        "duration": 1.369
    },
    {
        "text": "The thing is, we’re not really sure yet\nwhat those advantages are.",
        "start": 141.349,
        "duration": 3.43
    },
    {
        "text": "There hasn’t been enough research on how\nimmune systems change with age",
        "start": 144.779,
        "duration": 3.24
    },
    {
        "text": "to pinpoint exactly what might be at play.",
        "start": 148.019,
        "duration": 2.33
    },
    {
        "text": "Though, we might know a lot more in the coming\nyears,",
        "start": 150.349,
        "duration": 2.081
    },
    {
        "text": "as lots of researchers have been inspired\nby COVID-19 to look more closely at this!",
        "start": 152.43,
        "duration": 4.239
    },
    {
        "text": "That said, one thing that does seem to change\nwith age,",
        "start": 156.669,
        "duration": 3.251
    },
    {
        "text": "which is very relevant to this virus in particular,\nis the distribution of ACE2 receptors.",
        "start": 159.92,
        "duration": 5.659
    },
    {
        "text": "Those are the proteins that the SARS-CoV-2\nvirus uses to unlock and infect our cells.",
        "start": 165.579,
        "duration": 5.03
    },
    {
        "text": "They can be found in tissues throughout the\nbody.",
        "start": 170.609,
        "duration": 1.85
    },
    {
        "text": "But their presence in the nasopharynx is especially\nimportant,",
        "start": 172.459,
        "duration": 3.07
    },
    {
        "text": "as that’s where respiratory viruses like\nSARS-CoV-2 usually enter our bodies,",
        "start": 175.529,
        "duration": 4.371
    },
    {
        "text": "and where scientists believe these viruses\ncan hang out and multiply.",
        "start": 179.9,
        "duration": 2.929
    },
    {
        "text": "It’s possible, if kids have less ACE2 in\nthose tissues,",
        "start": 182.829,
        "duration": 3.33
    },
    {
        "text": "they can’t get a full-blown infection as\neasily,",
        "start": 186.159,
        "duration": 2.97
    },
    {
        "text": "and that could have something to do with them\nnot feeling symptoms.",
        "start": 189.129,
        "duration": 2.72
    },
    {
        "text": "And lo and behold, a May 2020 study in the",
        "start": 191.849,
        "duration": 2.39
    },
    {
        "text": "Journal of the American Medical Association\nfound that the activity of the ACE2 gene",
        "start": 194.239,
        "duration": 4.801
    },
    {
        "text": "was lower in children and increased with age.",
        "start": 199.04,
        "duration": 3.44
    },
    {
        "text": "Now, other studies which, as of yet, have\nnot been peer reviewed,",
        "start": 202.48,
        "duration": 3.239
    },
    {
        "text": "have suggested that ACE2 in the nasal cavities\ndrops again beyond the age of 60.",
        "start": 205.719,
        "duration": 5.33
    },
    {
        "text": "So, if those findings hold, this wouldn’t\nexplain why that group tends to",
        "start": 211.049,
        "duration": 4.011
    },
    {
        "text": "show more severe symptoms.",
        "start": 215.06,
        "duration": 1.67
    },
    {
        "text": "But even in older people, the expression of\nACE2 is",
        "start": 216.73,
        "duration": 2.399
    },
    {
        "text": "highly dependent on environmental factors.",
        "start": 219.129,
        "duration": 2.26
    },
    {
        "text": "For instance, grown-ups with respiratory allergies",
        "start": 221.389,
        "duration": 2.31
    },
    {
        "text": "seem to have less ACE2 in their nasal passages.",
        "start": 223.699,
        "duration": 2.49
    },
    {
        "text": "So anything like that which affects where\nand how much ACE2 a person has",
        "start": 226.189,
        "duration": 4.401
    },
    {
        "text": "may influence their likelihood of having an\nasymptomatic infection.",
        "start": 230.59,
        "duration": 3.519
    },
    {
        "text": "And it’s not just about ACE2.",
        "start": 234.109,
        "duration": 1.75
    },
    {
        "text": "Studies suggest the virus needs the help of\nanother cell surface protein",
        "start": 235.859,
        "duration": 3.1
    },
    {
        "text": "called TMPRSS2 to infect cells.",
        "start": 238.959,
        "duration": 2.34
    },
    {
        "text": "And kids also have fewer of those proteins\nin their nasal passages.",
        "start": 241.299,
        "duration": 3.45
    },
    {
        "text": "This actually leads really well into some\nof the ideas researchers have",
        "start": 244.749,
        "duration": 2.97
    },
    {
        "text": "for why some adults never show symptoms.",
        "start": 247.719,
        "duration": 2.33
    },
    {
        "text": "You see, some people have variations of the\nACE2 or TMPRSS2 genes",
        "start": 250.049,
        "duration": 3.53
    },
    {
        "text": "that lead to fewer of these proteins in their\nnasopharynx;",
        "start": 253.579,
        "duration": 3.391
    },
    {
        "text": "potentially to levels more like the amount\nseen in kids.",
        "start": 256.97,
        "duration": 2.53
    },
    {
        "text": "So they may stay asymptomatic simply because\nthe virus",
        "start": 259.5,
        "duration": 3.17
    },
    {
        "text": "can’t get a good foothold in them.",
        "start": 262.67,
        "duration": 1.62
    },
    {
        "text": "And when it comes to the nose and throat,",
        "start": 264.29,
        "duration": 1.809
    },
    {
        "text": "there are a lot of things that can affect\nwhether a virus establishes itself.",
        "start": 266.099,
        "duration": 3.521
    },
    {
        "text": "Like, the authors of a November 2020 paper\nin Frontiers in Immunology",
        "start": 269.62,
        "duration": 3.96
    },
    {
        "text": "hypothesize that some people do a better job\nof creating a defensive coating",
        "start": 273.58,
        "duration": 3.7
    },
    {
        "text": "of mucus in their nasopharynx.",
        "start": 277.28,
        "duration": 1.65
    },
    {
        "text": "Mucus might act as a physical barrier between\nviruses and cells,",
        "start": 278.93,
        "duration": 4.239
    },
    {
        "text": "so the viruses don’t get a chance to latch\nonto cells in the first place.",
        "start": 283.169,
        "duration": 2.961
    },
    {
        "text": "It also seems likely that a person’s frontline\nimmune defenses, or innate immunity,",
        "start": 286.13,
        "duration": 4.95
    },
    {
        "text": "plays a big role in whether or not they end\nup developing symptoms.",
        "start": 291.08,
        "duration": 3.08
    },
    {
        "text": "Studies suggest that SARS-CoV-2 is able to\nfly in under the radar of",
        "start": 294.16,
        "duration": 3.71
    },
    {
        "text": "some people’s innate immune systems.",
        "start": 297.87,
        "duration": 1.81
    },
    {
        "text": "Essentially, the virus might be able to buy\nitself enough time to set up shop",
        "start": 299.68,
        "duration": 3.65
    },
    {
        "text": "before the immune system catches on to its\npresence.",
        "start": 303.33,
        "duration": 2.78
    },
    {
        "text": "Meanwhile, in asymptomatic people, innate\nimmune cells seem to be",
        "start": 306.11,
        "duration": 3.58
    },
    {
        "text": "better at clearing out the virus quickly.",
        "start": 309.69,
        "duration": 2.14
    },
    {
        "text": "Like, studies have found that a significant\nnumber of patients with",
        "start": 311.83,
        "duration": 2.65
    },
    {
        "text": "life-threatening COVID-19 have problems with\ntheir interferons,",
        "start": 314.48,
        "duration": 4.36
    },
    {
        "text": "proteins that help spot viruses and interfere\nwith their replication.",
        "start": 318.84,
        "duration": 3.23
    },
    {
        "text": "By contrast, some asymptomatic people may\nhave extra-robust interferons that",
        "start": 322.07,
        "duration": 5.319
    },
    {
        "text": "throw a wrench into the virus’s plans early\nin the game.",
        "start": 327.389,
        "duration": 2.43
    },
    {
        "text": "So, a person's unique blend of interferon\ngenes may end up explaining",
        "start": 329.819,
        "duration": 4.35
    },
    {
        "text": "whether they develop symptoms, and not just\nbecause the proteins",
        "start": 334.169,
        "duration": 3.381
    },
    {
        "text": "interact with the virus directly.",
        "start": 337.55,
        "duration": 1.929
    },
    {
        "text": "Interferon activity also alerts T cells.",
        "start": 339.479,
        "duration": 2.291
    },
    {
        "text": "These are white blood cells that play a central\nrole in the other",
        "start": 341.77,
        "duration": 2.53
    },
    {
        "text": "major branch of immunity: adaptive immunity.",
        "start": 344.3,
        "duration": 2.74
    },
    {
        "text": "That’s the one that remembers threats and\ndeploys specific weapons",
        "start": 347.04,
        "duration": 3.2
    },
    {
        "text": "when it spots something it recognizes.",
        "start": 350.24,
        "duration": 1.6
    },
    {
        "text": "And yep, it also probably plays a role in\nwhether or not",
        "start": 351.84,
        "duration": 3.229
    },
    {
        "text": "an infected person shows symptoms.",
        "start": 355.069,
        "duration": 1.731
    },
    {
        "text": "One way adaptive immunity might do this is\nby being “primed” to attack a virus",
        "start": 356.8,
        "duration": 4.179
    },
    {
        "text": "because of previous exposure to other, similar\nviruses,",
        "start": 360.979,
        "duration": 3.16
    },
    {
        "text": "like, in this case, the coronaviruses that\ncause colds.",
        "start": 364.139,
        "duration": 3.261
    },
    {
        "text": "The idea here is that SARS-CoV-2 may look\nenough like these other viruses",
        "start": 367.4,
        "duration": 5.009
    },
    {
        "text": "that people who’ve had infections, especially\nrecently,",
        "start": 372.409,
        "duration": 3.171
    },
    {
        "text": "have a bit of a pre-loaded adaptive response\nthat helps them clear the virus out faster.",
        "start": 375.58,
        "duration": 3.92
    },
    {
        "text": "And there has been some evidence to back this\nhypothesis.",
        "start": 379.5,
        "duration": 2.47
    },
    {
        "text": "For instance, one small study found that COVID\npatients who had recently",
        "start": 381.97,
        "duration": 3.689
    },
    {
        "text": "had a cold-causing coronavirus infection were\nless likely to end up in intensive care.",
        "start": 385.659,
        "duration": 5.191
    },
    {
        "text": "This may not extend all the way to showing\nno symptoms, though.",
        "start": 390.85,
        "duration": 2.819
    },
    {
        "text": "And having your immune system primed like\nthis has also been implicated",
        "start": 393.669,
        "duration": 3.291
    },
    {
        "text": "in severe infections, so clearly we have more\nto learn.",
        "start": 396.96,
        "duration": 3.75
    },
    {
        "text": "Still, there are other ways the adaptive immune\nsystem could be",
        "start": 400.71,
        "duration": 2.66
    },
    {
        "text": "suppressing a person’s symptoms.",
        "start": 403.37,
        "duration": 1.88
    },
    {
        "text": "Like, research also suggests that T cells\nstay cooler",
        "start": 405.25,
        "duration": 3.09
    },
    {
        "text": "under pressure in asymptomatic individuals.",
        "start": 408.34,
        "duration": 1.99
    },
    {
        "text": "While they send up a loud alert, they also\nsend out chill vibes.",
        "start": 410.33,
        "duration": 4.26
    },
    {
        "text": "So, basically, they tell the immune system\n“There’s a problem here,",
        "start": 414.59,
        "duration": 3.74
    },
    {
        "text": "but don’t freak out, ok?",
        "start": 418.33,
        "duration": 1.639
    },
    {
        "text": "We got this.”",
        "start": 419.969,
        "duration": 1.0
    },
    {
        "text": "And that, too, could be a clue as to why some\npeople don’t show symptoms.",
        "start": 420.969,
        "duration": 3.271
    },
    {
        "text": "See, a lot of the symptoms of a viral infection\nhave less to do with",
        "start": 424.24,
        "duration": 2.889
    },
    {
        "text": "the virus than the immune response to it.",
        "start": 427.129,
        "duration": 2.561
    },
    {
        "text": "Just look at cold and flu viruses.",
        "start": 429.69,
        "duration": 2.039
    },
    {
        "text": "Some people who catch them don’t feel a\nthing,",
        "start": 431.729,
        "duration": 2.201
    },
    {
        "text": "while others get knocked down for days.",
        "start": 433.93,
        "duration": 1.62
    },
    {
        "text": "And that could have more to do with their\nimmune systems than the strain they caught.",
        "start": 435.55,
        "duration": 3.98
    },
    {
        "text": "For instance, in a 2016 study published in\nClinical & Experimental Immunology,",
        "start": 439.53,
        "duration": 4.9
    },
    {
        "text": "researchers intentionally exposed subjects\nto an influenza virus.",
        "start": 444.43,
        "duration": 3.229
    },
    {
        "text": "Those that went on to exhibit symptoms had\nhigher levels of immune signaling molecules,",
        "start": 447.659,
        "duration": 4.641
    },
    {
        "text": "while the reaction was muted in those who\ngot infected but didn’t feel sick.",
        "start": 452.3,
        "duration": 3.369
    },
    {
        "text": "And researchers have seen similar muted responses\nin asymptomatic COVID-19 cases.",
        "start": 455.669,
        "duration": 4.47
    },
    {
        "text": "Like, a June 2020 study of people in China\nfound higher circulating levels",
        "start": 460.139,
        "duration": 3.83
    },
    {
        "text": "of antibodies and immune signaling proteins\nin people with symptoms.",
        "start": 463.969,
        "duration": 3.711
    },
    {
        "text": "Another thing that doesn’t seem to happen\nin people who aren’t",
        "start": 467.68,
        "duration": 2.68
    },
    {
        "text": "noticeably sickened by COVID-19 is a lot of\ndisease resistance.",
        "start": 470.36,
        "duration": 3.75
    },
    {
        "text": "That’s the term immunologists use to describe\nthe degree of",
        "start": 474.11,
        "duration": 3.0
    },
    {
        "text": "pushing back against a pathogen that the immune\nsystem does.",
        "start": 477.11,
        "duration": 3.309
    },
    {
        "text": "People whose innate and adaptive immune systems\ngo ham on a pathogen",
        "start": 480.419,
        "duration": 3.97
    },
    {
        "text": "tend to end up with more severe symptoms.",
        "start": 484.389,
        "duration": 2.221
    },
    {
        "text": "Though, again, balance seems to be key.",
        "start": 486.61,
        "duration": 2.5
    },
    {
        "text": "As we talked about earlier, not having an\neffective immune response can",
        "start": 489.11,
        "duration": 3.07
    },
    {
        "text": "let a pathogen get a foothold and make it\nharder to oust later on.",
        "start": 492.18,
        "duration": 3.12
    },
    {
        "text": "And having an immune system that’s well-primed\nfor attack,",
        "start": 495.3,
        "duration": 2.76
    },
    {
        "text": "like from a previous infection, can help you\nclear out an invader quickly and quietly.",
        "start": 498.06,
        "duration": 4.27
    },
    {
        "text": "But too strongly resisting a pathogen can\ncause collateral damage,",
        "start": 502.33,
        "duration": 3.98
    },
    {
        "text": "especially if the virus has already managed\nto multiply a lot.",
        "start": 506.31,
        "duration": 3.03
    },
    {
        "text": "Basically, a desperate attempt to kill an\ninvader can kill healthy tissue, too.",
        "start": 509.34,
        "duration": 4.35
    },
    {
        "text": "So you want your immune system to do its job,\nbut not be an overachiever.",
        "start": 513.69,
        "duration": 3.8
    },
    {
        "text": "And this goes back to those cool under pressure\nT cells.",
        "start": 517.49,
        "duration": 2.78
    },
    {
        "text": "It may be that many parts of the immune systems\nof people",
        "start": 520.27,
        "duration": 2.83
    },
    {
        "text": "with asymptomatic COVID-19 don’t act desperately,\nno matter how bad things look.",
        "start": 523.1,
        "duration": 5.22
    },
    {
        "text": "They go about their business calmly and efficiently\nwithout panicking.",
        "start": 528.32,
        "duration": 3.4
    },
    {
        "text": "But again, we don’t have a lot of specifics\nas to",
        "start": 531.72,
        "duration": 2.65
    },
    {
        "text": "what that looks like on the cellular level.",
        "start": 534.37,
        "duration": 2.2
    },
    {
        "text": "Immune systems are really complex, and there\nsimply hasn’t been enough research",
        "start": 536.57,
        "duration": 4.16
    },
    {
        "text": "on people with and without symptomatic infections\nto",
        "start": 540.73,
        "duration": 2.73
    },
    {
        "text": "suss out all the moving molecular parts.",
        "start": 543.46,
        "duration": 2.17
    },
    {
        "text": "As you can see, the possible reasons for asymptomatic\ninfections have been piling up.",
        "start": 545.63,
        "duration": 4.49
    },
    {
        "text": "From slowing the virus from the get-go to\ngently dealing with a full-blown infection,",
        "start": 550.12,
        "duration": 4.81
    },
    {
        "text": "one thing is clear: there isn’t just one\nanswer as to",
        "start": 554.93,
        "duration": 2.75
    },
    {
        "text": "why some people don’t get visibly sick.",
        "start": 557.68,
        "duration": 1.82
    },
    {
        "text": "It might even seem like we’re turning up\nmore questions than answers.",
        "start": 559.5,
        "duration": 2.9
    },
    {
        "text": "But that isn’t a bad thing!",
        "start": 562.4,
        "duration": 1.66
    },
    {
        "text": "This mystery about asymptomatic COVID-19 has\nspurred a ton of research into",
        "start": 564.06,
        "duration": 4.25
    },
    {
        "text": "the inner workings of our immune system.",
        "start": 568.31,
        "duration": 2.09
    },
    {
        "text": "And as with all kinds of science, figuring\nout the right questions to ask is",
        "start": 570.4,
        "duration": 4.13
    },
    {
        "text": "the first step to getting answers.",
        "start": 574.53,
        "duration": 2.09
    },
    {
        "text": "Thanks for watching this episode of SciShow!",
        "start": 576.62,
        "duration": 1.51
    },
    {
        "text": "If you have any follow up questions about\nimmunity or COVID-19,",
        "start": 578.13,
        "duration": 2.62
    },
    {
        "text": "or just random questions about science, feel\nfree to ask them in the comments!",
        "start": 580.75,
        "duration": 4.56
    },
    {
        "text": "We love hearing what you want to know more\nabout.",
        "start": 585.31,
        "duration": 2.03
    }
]